| Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients A Anand, P Verhoeff, N Seneca, SS Zoghbi, JP Seibyl, DS Charney, ... American Journal of Psychiatry 157 (7), 1108-1114, 2000 | 282 | 2000 |
| Evaluation of anesthesia effects on [18F] FDG uptake in mouse brain and heart using small animal PET H Toyama, M Ichise, JS Liow, DC Vines, NM Seneca, KJ Modell, J Seidel, ... Nuclear medicine and biology 31 (2), 251-256, 2004 | 203 | 2004 |
| Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration A Kugaya, NM Seneca, PJ Snyder, SA Williams, RT Malison, RM Baldwin, ... Neuropsychopharmacology 28 (2), 413-420, 2003 | 195 | 2003 |
| P-glycoprotein function at the blood–brain barrier in humans can be quantified with the substrate radiotracer 11C-N-desmethyl-loperamide WC Kreisl, JS Liow, N Kimura, N Seneca, SS Zoghbi, CL Morse, ... Journal of Nuclear Medicine 51 (4), 559-566, 2010 | 171 | 2010 |
| Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: A comparison of the agonist radioligand [11C]MNPA and antagonist [11C … N Seneca, SJ Finnema, L Farde, B Gulyás, HV Wikström, C Halldin, ... Synapse 59 (5), 260-269, 2006 | 131 | 2006 |
| Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2 N Seneca, B Gulyás, A Varrone, M Schou, A Airaksinen, J Tauscher, ... Psychopharmacology 188, 119-127, 2006 | 101 | 2006 |
| Preparation of highly specific radioactivity [18F] flumazenil and its evaluation in cynomolgus monkey by positron emission tomography NN Ryzhikov, N Seneca, RN Krasikova, NA Gomzina, E Shchukin, ... Nuclear medicine and biology 32 (2), 109-116, 2005 | 100 | 2005 |
| 11C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas E Park, JD Gallezot, A Delgadillo, S Liu, B Planeta, SF Lin, KC O’Connor, ... European journal of nuclear medicine and molecular imaging 42, 1081-1092, 2015 | 99 | 2015 |
| Synthesis and Evaluation of [N-methyl-11C]N-Desmethyl-loperamide as a New and Improved PET Radiotracer for Imaging P-gp Function N Lazarova, SS Zoghbi, J Hong, N Seneca, E Tuan, RL Gladding, JS Liow, ... Journal of medicinal chemistry 51 (19), 6034-6043, 2008 | 98 | 2008 |
| D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse model M Skinbjerg, JS Liow, N Seneca, J Hong, S Lu, A Thorsell, M Heilig, ... Neuroimage 50 (4), 1402-1407, 2010 | 89 | 2010 |
| P-glycoprotein function at the blood–brain barrier imaged using 11C-N-desmethyl-loperamide in monkeys JS Liow, W Kreisl, SS Zoghbi, N Lazarova, N Seneca, RL Gladding, ... Journal of nuclear medicine 50 (1), 108-115, 2009 | 89 | 2009 |
| Correlation of 18F-FDG PET/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of … A Roivainen, S Hautaniemi, T Möttönen, P Nuutila, V Oikonen, R Parkkola, ... European journal of nuclear medicine and molecular imaging 40, 403-410, 2013 | 86 | 2013 |
| [11C] AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain ME Pierson, J Andersson, S Nyberg, DJ McCarthy, SJ Finnema, K Varnäs, ... Neuroimage 41 (3), 1075-1085, 2008 | 85 | 2008 |
| Human brain imaging and radiation dosimetry of 11C-N-desmethyl-loperamide, a PET radiotracer to measure the function of P-glycoprotein N Seneca, SS Zoghbi, JS Liow, W Kreisl, P Herscovitch, K Jenko, ... Journal of nuclear medicine 50 (5), 807-813, 2009 | 82 | 2009 |
| A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C] MNPA in cynomolgus monkey SJ Finnema, N Seneca, L Farde, E Shchukin, J Sóvágó, B Gulyás, ... Nuclear medicine and biology 32 (4), 353-360, 2005 | 80 | 2005 |
| Kinetic modeling of the tau PET tracer 18F-AV-1451 in human healthy volunteers and Alzheimer disease subjects O Barret, D Alagille, S Sanabria, RA Comley, RM Weimer, E Borroni, ... Journal of Nuclear Medicine 58 (7), 1124-1131, 2017 | 79 | 2017 |
| Cerebral benzodiazepine receptors in depressed patients measured with [123I] iomazenil SPECT A Kugaya, G Sanacora, NPLG Verhoeff, M Fujita, GF Mason, NM Seneca, ... Biological psychiatry 54 (8), 792-799, 2003 | 73 | 2003 |
| Quantification of brain phosphodiesterase 4 in rat with (R)-[11C] rolipram-PET M Fujita, SS Zoghbi, MS Crescenzo, J Hong, JL Musachio, JQ Lu, JS Liow, ... Neuroimage 26 (4), 1201-1210, 2005 | 64 | 2005 |
| Occupancy of dopamine D2 and D3 and serotonin 5-HT1A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain … N Seneca, SJ Finnema, I Laszlovszky, B Kiss, A Horváth, G Pásztor, ... Psychopharmacology 218, 579-587, 2011 | 59 | 2011 |
| Quantification of nicotinic acetylcholine receptors in human brain using [123I]5-I-A-85380 SPET M Fujita, M Ichise, CH Van Dyck, SS Zoghbi, G Tamagnan, AG Mukhin, ... European journal of nuclear medicine and molecular imaging 30, 1620-1629, 2003 | 57 | 2003 |
